Clinical Trial ECOGTHOE1505-M


A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB (> or = 4 cm)- IIIA Non-Small Cell Lung Cancer (NSCLC)

Principal Investigator(s)

John Murray


  • Protocol No. ECOGTHOE1505-M
  • Open Date: 07/27/2007
  • Staging: Phase III
  • Age Group: Adults
  • Scope: National
  • Objective: To evaluate overall survival with chemotherapy with or without Bevacizumab used in the adjuant setting in patients with resected stage IB - IIIA NSCLC.
  • Disease Sites: Non Small Cell
  • Therapies: Chemotherapy - cytotoxic; Molecular Targeted Agents / Immunotherapy / Biologics
  • Drugs: None Specified
  • Participating Institutions: Meharry Medical College; Baptist Hospital
  • Secondary Protocol No: E1505



Learn More

You do not have JavaScript enabled. This site works better with JavaScript turned on.